# EDGAR Filing Document

**Accession Number:** 0001517681
**File Stem:** 0001641172-25-020886
**Filing Date:** 2025-7
**Character Count:** 2147
**Document Hash:** 40d47ed9e6a84e64ee197f79f3e8c94e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-020886.hdr.sgml**: 20250911

**ACCESSION NUMBER**: 0001641172-25-020886

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250724

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Propanc Biopharma, Inc.
- **CENTRAL INDEX KEY:** 0001517681
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 330662986
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 302/6 BUTLER STREET
- **CITY:** CAMBERWELL, VICTORIA
- **STATE:** C3
- **ZIP:** 3124
- **BUSINESS PHONE:** 61-03-9882-0780

**MAIL ADDRESS:**
- **STREET 1:** 302/6 BUTLER STREET
- **CITY:** CAMBERWELL, VICTORIA
- **STATE:** C3
- **ZIP:** 3124

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Propanc Health Group Corp
- **DATE OF NAME CHANGE:** 20110408

July 24, 2025

United States Securities and Exchange Commission

Division of Corporation Finance

Attn: Tyler Howes

100 F Street, N.E.

Washington, DC 20549

---

| | |
|:---|:---|
| **Re:** | **Propanc Biopharma, Inc.** |
|  | **Amendment No. 5 to Registration Statement on Form S-1** |
|  | **Filed May 30, 2025** |
|  | **File No. 333-282886** |

---

Ladies and Gentlemen:

The undersigned registrant (the "Registrant") hereby requests that the Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Amended Registration Statement on Form S-1 to become effective on July 28, 2025 at 4:30 p.m. Eastern Daylight Time, or as soon thereafter as practicable.

The Registrant authorizes Chase Chandler of Brunson Chandler & Jones, PLLC, outside counsel to the Registrant, to verbally alter the requested date and time of effectiveness of the Registration Statement with the Commission. Please call Mr. Chandler at (801) 303-5772 with any questions.

Very truly yours,

---

| | |
|:---|:---|
| **Propanc Biopharma, Inc.** |  |
| */s/ James Nathanilesz* | |
| James Nathanilesz |  |
| Chief Executive Officer |  |

---